OnKure Therapeutics, Inc. (OKUR)
3.58
+0.02
(+0.56%)
USD |
NASDAQ |
Sep 04, 16:00
3.40
-0.18
(-5.03%)
Pre-Market: 20:00
OnKure Therapeutics SG&A Expense (TTM) : 15.19M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.19M |
| March 31, 2026 | 14.61M |
| December 31, 2025 | 14.69M |
| September 30, 2025 | 11.28M |
| June 30, 2025 | 11.46M |
| March 31, 2025 | 13.52M |
| December 31, 2024 | 14.16M |
| September 30, 2024 | 21.56M |
| June 30, 2024 | 25.06M |
| March 31, 2024 | 25.93M |
| December 31, 2023 | 26.44M |
| September 30, 2023 | 23.24M |
| June 30, 2023 | 19.88M |
| Date | Value |
|---|---|
| March 31, 2023 | 17.54M |
| December 31, 2022 | 16.14M |
| September 30, 2022 | 15.46M |
| June 30, 2022 | 14.99M |
| March 31, 2022 | 13.64M |
| December 31, 2021 | 11.65M |
| September 30, 2021 | 8.125M |
| June 30, 2021 | 5.359M |
| March 31, 2021 | 3.292M |
| December 31, 2020 | 2.474M |
| September 30, 2020 | 2.474M |
| June 30, 2020 | 1.806M |
| March 31, 2020 | 0.924M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Theriva Biologics, Inc. | 6.919M |
| Yarrow Bioscience, Inc. | 10.57M |
| Nkarta, Inc. | 32.74M |
| Unicycive Therapeutics, Inc. | 23.53M |